Financial information

facts and figures, shareholder 's guide & press releases

Events & financial agenda

Sales figures and results announcements and assembly dates

23rd September 2020
Half year results 2020
Shareholders' guide

Listed on Alternext Paris
Eligible PEA PME
Initial listing: 25 April 2014
Number of shares: 15 247 329
ICB Classification (Sector):
4535 Medical Equipment

Identification codes:
Name: THERACLION
ISIN: FR0010120402
LEI: 9695007X7HA7A1GYD29
Ticker: ALTHE
Bloomberg: ALTHE.FP
Reuters: ALTHE.FA

Annual Closure: 31 December

Liquidity contract:
CM-CIC Market Solutions

Analyst coverage:
Farny Meindre CM-CIC Market Solutions
Thibault Voglimacci-Stephanopoli Invest

Latest public analyzes available:

Etude Invest Securities  (in French)

Shareholders
Press releases

Newsworthy statements, milestones and announcements

February 12th 2019
€11.8 million new financing package concluded
February 2nd 2019
Revenu 2018
October 24th 2018
Tübingen/Fus
April 3rd 2014
Theraclion obtains FDA approval for IDE
April 3rd 2014
FDA approval for IDE in USA for Breast Fibroadenoma
December 12th 2012
CE Mark breast fibroadenoma
Financial reports & presentations

Key economic and financial information
(find more information on the French pages)

Contact us

Move to what moves you - for profit AND for people.
Get in touch